... that our singular focus on HIV can deliver important new medicines, maintaining our absolute commitment to the HIV/AIDS global response," said Dr The submission included data from four pivotal Phase III clinical trials that treated 2,557 adults (who ...
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-announces-US-approval-of-Tivicay-d/ArticleNewsFeed/Article/detail/820330?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/ViiV-Healthcare-announces-US-approval-of-Tivicay-d/ArticleNewsFeed/Article/detail/820330?ref=25
No comments:
Post a Comment